Form 8-K - Current report:
SEC Accession No. 0001193125-20-162330
Filing Date
2020-06-05
Accepted
2020-06-05 17:25:56
Documents
2
Period of Report
2020-06-05
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d925242d8k.htm 8-K 22945
2 EX-16.1 d925242dex161.htm EX-16.1 2524
  Complete submission text file 0001193125-20-162330.txt   26580
Mailing Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000
Business Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000 61(0)3 8692-7222
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 20947406
SIC: 2834 Pharmaceutical Preparations